GlassScriptPhysician profile
Ayaz Ahmed
NPI 1235247990
$2,658.01
in general payments reported to CMS, 2019-2025
41 companies · $393 in 2025
The $393 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $361 · 2021: $562 · 2022: $336 · 2023: $413 · 2024: $321 · 2025: $393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,109 · Entertainment: $18.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,108.74 |
| Entertainment | $18.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $461.87 | 2019-2024 | |
| Glaxosmithkline, LLC. | $458.19 | 2019-2025 | Trelegy Ellipta |
| Astellas Pharma US INC | $267.61 | 2019-2025 | Veozah, Myrbetriq |
| Astrazeneca Pharmaceuticals LP | $153.57 | 2022-2025 | Breztri, Airsupra, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $118.41 | 2022-2025 | |
| Xeris Pharmaceuticals, INC. | $101.59 | 2022-2023 | Gvoke Hypopen |
| Novo Nordisk INC | $85.87 | 2019-2024 | Ozempic, Rybelsus |
| Amarin Pharma, INC. | $84.87 | 2019-2021 | |
| Exact Sciences Corporation | $81.37 | 2023-2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $63.37 | 2019-2025 | |
| Boston Scientific Corporation | $51.46 | 2022-2025 | Watchman Access System |
| Lilly USA, LLC | $49.35 | 2021-2023 | Amyvid, Mounjaro |
| Radius Health, INC. | $40.96 | 2025 | Tymlos |
| Edwards Lifesciences Corporation | $38.43 | 2025 | Sapien 3 Ultra Resilia |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $36.29 | 2024-2025 | Caplyta |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $36.12 | 2021-2024 | Freestyle Libre 3 |
| Beta Bionics, INC. | $34.81 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Averitas Pharma INC. | $34.74 | 2025 | Qutenza |
| Seqirus USA INC | $34.24 | 2024 | Fluad, Flucelvax |
| Merck Sharp & Dohme LLC | $33.89 | 2021 | |
| Novartis Pharmaceuticals Corporation | $30.45 | 2019-2023 | |
| Amgen INC. | $29.60 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $23.97 | 2020 | |
| Medtronic, INC. | $22.66 | 2022 | |
| Pulmonx Corporation | $22.40 | 2023 | Chartis Catheter, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Axsome Therapeutics, INC. | $21.90 | 2025 | Auvelity |
| Daiichi Sankyo INC. | $21.17 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.30 | 2024 | Jardiance |
| Alexion Pharmaceuticals, INC. | $18.96 | 2021 | |
| Optos, INC. | $18.57 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Corcept Therapeutics | $18.26 | 2025 | Korlym |
| Ultragenyx Pharmaceutical INC. | $17.77 | 2024 | Crysvita |
| Insulet Corporation | $17.45 | 2024 | Omnipod |
| Paratek Pharmaceuticals, INC. | $17.31 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $16.77 | 2021 | |
| Abbvie INC. | $15.49 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.22 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.19 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.85 | 2019 | |
| Mylan Specialty L.P. | $10.88 | 2019 | |
| Sunovion Pharmaceuticals INC. | $10.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayaz Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.